Ładuje się......
Advances in the assessment of minimal residual disease in mantle cell lymphoma
The clinical impact of minimal residual disease detection at early time points or during follow-ups has been shown to accurately predict relapses among patients with lymphomas, mainly in follicular and diffuse large B cell lymphoma. The field of minimal residual disease testing in mantle cell lympho...
Zapisane w:
| Wydane w: | J Hematol Oncol |
|---|---|
| Główni autorzy: | , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
BioMed Central
2020
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7513535/ https://ncbi.nlm.nih.gov/pubmed/32972438 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-020-00961-8 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|